Portola Pharmaceuticals Total Liabilities

Portola Pharmaceuticals (PTLA) currently reports a total liabilities of $440M as of March 2020. That compares with $350M in the prior-year period — up 26.2% year over year. Use the charts on this page to explore Portola Pharmaceuticals's total liabilities history and peer comparisons.

Portola Pharmaceuticals's total liabilities increased from $350M to $440M — a 26.2% year-over-year increase (period ending March 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Portola Pharmaceuticals reported $440M in total liabilities as of March 2020. That compares with $350M in the prior-year period — up 26.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $440M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Portola Pharmaceuticals, and consider following PTLA for alerts when major investors trade the stock.

Portola Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $440M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PTLA with unrelated industries.